CNBP’s latest partner launch successfully took place 3 July 2015, with industry partner Olympus, at Olympus Headquarters, Tokyo, Japan.
The launch and associated visit over two days, saw members of the CNBP leadership team (Mark Hutchinson, Jim Piper, Brant Gibson, and Mel Trebilcock) meet with key Olympus Executives to actively reinforce and advance collaboration between both organisations, with a view to facilitating Industry-Research benefits for both parties.
With presentations from both CNBP and Olympus Executives, a symbolic CNBP offering of plaque and handmade scientific symbols, as well as a number of associated meetings, the launch was seen as highly successful by the Centre, with a number of positive outcomes. This included the broadening of the CNBP and Olympus personal relationships, the development of clearly defined expectations and involvement of both partners, as well as the clear communication of CNBP’s commitment to commercial outcomes with long term societal impact, in alignment with Olympus corporate vision.
Wide-ranging dialogue on future partnership opportunities were also undertaken by participants, with CNBP Director Mark Hutchinson noting that he saw value in “growing CNBP collaboration with Olympus in all three of its corporate domains – medical, science and imaging.” And that talks with Olympus in this regard had proved encouraging.
Discussions on the future directions of the partnership with Olympus and CNBP, both within Australia and internationally had also been promising said Hutchinson. Olympus currently funds two researchers, located at CNBP’s Macquarie University node in Sydney, Australia. Agreement by both partners to explore opportunities provided by the Australian Government Beacon fellowship scheme for short term international research collaborations was also a positive.
Feedback from Olympus Australia, who were in attendance at the launch, advised that Olympus HQ had a very good understanding of both the relationship and expectations of the partnership. Also, that the strategies of both organisations were well aligned in aiming to discover, develop and produce products, which will have a long term contribution and beneficial impact to society.
The CNBP visit included a tour of the head office of the Olympus Tokyo corporate area, as well as the training facility – the Olympus Techno Lab – and concluded on the second day with a tour and additional related meetings and presentations at the Olympus R&D facility.
Hutchinson, in summing up the launch, expressed pleasure in the “open interaction and around-the-table discussions with Mr Okubo, Mr Inoue and Mr Arinobe from Olympus Tokyo”, noting that the Olympus Executives had “seemed impressed by CNBP’s approach and model to translational research.” He concluded, “Olympus is a valued member of our partner global partnership network, which is continuing to grow within industry, university and government environments.”
Key personnel in attendance from Olympus Tokyo Headquarters for the launch were:
• Mr Toshihiko Okubo, Executive Officer Division Manager, Scientific Solutions Business Strategy Division and Scientific Solutions Business Global Marketing Division
• Mr Motoki Inoue, Manager Sales Marketing 1-Group, Scientific Solutions Sales and Marketing Department and Scientific Solutions Business Strategy Division
• Mr Eisuke Arinobe, Manager Academy Planning Group, Scientific Solutions Sales and Marketing Department and Scientific Solutions Business Strategy Division
Key personnel in attendance from Olympus Australia for the launch were:
• Mr JianShen, Sales Manager, MIS – Olympus Australia
• Dr. Kim Everuss, Sales Manager, MIS – Olympus Australia
Key personnel in attendance from the Centre for Nanoscale BioPhotonics for the launch were:
• Prof Mark Hutchinson, CNBP Director
• Prof Jim Piper, CNBP Node Leader, Macquarie University
• A/Prof Brant Gibson, CNBP Node Leader, RMIT University
• Ms Melodee Trebilcock, CNBP Business Development and Events Officer